Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models.

Authors: Fujimoto, M  Takaki, E  Hayashi, T  Kitaura, Y  Tanaka, Y  Inouye, S  Nakai, A 
Citation: Fujimoto M, etal., J Biol Chem. 2005 Oct 14;280(41):34908-16. Epub 2005 Jul 28.
Pubmed: (View Article at PubMed) PMID:16051598
DOI: Full-text: DOI:10.1074/jbc.M506288200

Polyglutamine diseases are inherited neurodegenerative diseases characterized by misfolding and aggregation of proteins possessing expanded polyglutamine repeats. As overexpression of some heat shock protein (Hsp) suppresses polyglutamine aggregates and cell death, it is assumed that combined overexpression of Hsps will suppress that more effectively. Here, we examined the impact of active forms of heat shock transcription factor 1 (HSF1), which induces a set of Hsps, on polyglutamine inclusion formation and disease progression. We found that active HSF1 suppressed polyglutamine inclusion formation more significantly than any combination of Hsps in culture cells, possibly by regulating expression of unknown genes, as well as major Hsps. We crossed R6/2 Huntington disease mice with transgenic mice expressing an active HSF1 (HSF1Tg). Analysis of the skeletal muscle revealed that the polyglutamine inclusion formation and its weight loss were improved in R6/2/HSF1Tg mice. Unexpectedly, the life span of R6/2/HSF1Tg mice was significantly improved, although active HSF1 is not expressed in the brain. These results indicated that active HSF1 has a strong inhibitory effect on polyglutamine aggregate formation in vivo and in vitro.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 10402372
Created: 2015-10-21
Species: All species
Last Modified: 2015-10-21
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.